Live Breaking News & Updates on Karl Mahler|Page 4

Stay updated with breaking news from Karl mahler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

F. Hoffmann-La Roche Ltd: CHMP recommends EU approval of Roche's Polivy combination for people with previously untreated diffuse large B-cell lymphoma

Polivy plus R-CHP showed first clinically meaningful improvement in PFS with comparable safety in people with previously untreated diffuse large B-cell lymphoma (DLBCL) over the standard of care in more ....

United States , Nathalie Meetz , Polatuzumab Vedotin , Karl Mahler , Sabine Borngr , Gerard Tobin , Bruno Eschli , Birgit Masjost , Sileia Urech , Loren Kalm , Karsten Kleine , Lymphoma Study Association , World Health Organization , Roche Group , Roche Group Media Relations , Lymphoma Academic Research Organisation , Lugano Response Criteria , Dow Jones Sustainability Indices , Chugai Pharmaceutical , Cancer Incidence , Previously Untreated Diffuse Largeb Cell ,

F. Hoffmann-La Roche Ltd: Roche to present data across broad and impactful neuroscience portfolio at 2022 AAN Annual Meeting

First data showing OCREVUS treatment effect on disability progression in non-active secondary progressive multiple sclerosis and further data in primary progressive MS will be presentedEvrysdi data continue ....

United States , South Korea , Nathalie Meetz , Levi Garraway , Karl Mahler , Sabine Borngr , Gerard Tobin , Bruno Eschli , Birgit Masjost , Loren Kalm , Impact Of Administration Ocrelizumab , Sclerosis Care Center , Drug Administration , Head Of Global Product Development , Risdiplam Clinical Trial Development Program , European Union , Roche Group , American Academy Of Neurology , European Medicines Agency , Roche Group Media Relations , American Academy , Annual Meeting , Chief Medical Officer , Global Product , Suboptimal Response , Prior Disease Modifying Therapies ,

F. Hoffmann-La Roche Ltd: Roche donates additional medicines and diagnostics for Ukraine

Basel, 23 March 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the donation of additional medicines and diagnostics to Ukraine. Beyond the already communicated 150,000 packs of an antibiotic ....

United States , Nathalie Meetz , Birgit Masjost , Karl Mahler , Loren Kalm , Sabine Borngr , Gerard Tobin , Bruno Eschli , Roche Group , Roche Group Media Relations , Dow Jones Sustainability Indices , Chugai Pharmaceutical ,

F. Hoffmann-La Roche Ltd: New data for Roche's Evrysdi (risdiplam) demonstrate long-term efficacy and safety in a broad population of people with spinal muscular atrophy (SMA)

Long-term efficacy data from the pivotal SUNFISH study confirm increases in motor function are sustained at three years while adverse events decreased over the same periodPart 2 of SUNFISH showed Evrysdi ....

United Kingdom , United States , Nathalie Meetz , Levi Garraway , Karl Mahler , Sabine Borngr , Gerard Tobin , Bruno Eschli , Laurent Servais , Birgit Masjost , Loren Kalm , Muscular Dystrophy Association , Society For Medicines Research , Toddler Development , British Pharmacological Society , Drug Administration , Head Of Global Product Development , Oxford Neuromuscular Centre , European Medicines Agency , Roche Group , Office Of Orphan Products Development , Roche Group Media Relations , Scientific Conference , Paediatric Neuromuscular Diseases , Motor Function Measure , Revised Upper Limb Module ,

F. Hoffmann-La Roche Ltd: Roche provides molecular testing solutions to identify and differentiate SARS-CoV-2 Omicron variants of concern

Roche and its subsidiary, Tib Molbiol, confirm that it has tests for research use that identify the SARS-CoV-2 subvariants of concern, Omicron: BA.1, BA.1.1, BA.2, BA.2.2, BA.3 and DeltaThe World ....

United States , Nathalie Meetz , Karl Mahler , Sabine Borngr , Gerard Tobin , Bruno Eschli , Birgit Masjost , Loren Kalm , Thomas Schinecker , Roche Group , World Health Organization , Drug Administration , Population Health Management , Roche Group Media Relations , Roche Diagnostics , Lightmix Modular , Population Health , Emergency Use Authorization , Dow Jones Sustainability Indices , Chugai Pharmaceutical ,